Tag:

Vivopharma

Latest Headlines

Latest Headlines

ViroPharma, Halozyme tackle hereditary angioedema treatment

ViroPharma ($VPHM) and Halozyme ($HALO) said they have generated positive early data in a Phase II trial of a drug delivery platform used to treat hereditary angioedema, a life-threatening immune